Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

334 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma.
Uramoto H, Shimokawa H, Hanagiri T, Kuwano M, Ono M. Uramoto H, et al. Lung Cancer. 2011 Sep;73(3):361-5. doi: 10.1016/j.lungcan.2011.01.008. Epub 2011 Feb 18. Lung Cancer. 2011. PMID: 21315472
Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patients.
Uramoto H, Osaki T, Inoue M, Taga S, Takenoyama M, Hanagiri T, Yoshino I, Nakanishi R, Ichiyoshi Y, Yasumoto K. Uramoto H, et al. Eur J Cancer. 1999 Oct;35(10):1462-5. doi: 10.1016/s0959-8049(99)00157-4. Eur J Cancer. 1999. PMID: 10673978
Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K. Oyama T, et al. Among authors: uramoto h. Anticancer Res. 2000 Jan-Feb;20(1B):505-10. Anticancer Res. 2000. PMID: 10769714
Aggressive surgical treatment of multiple primary lung cancers.
Uramoto H, Nakanishi R, Osaki T, Yoshino I, Yasumoto K. Uramoto H, et al. Scand Cardiovasc J. 2000 Dec;34(6):603-5. doi: 10.1080/140174300750064567. Scand Cardiovasc J. 2000. PMID: 11214016
Vacuolar H(+)-ATPase: functional mechanisms and potential as a target for cancer chemotherapy.
Torigoe T, Izumi H, Ise T, Murakami T, Uramoto H, Ishiguchi H, Yoshida Y, Tanabe M, Nomoto M, Kohno K. Torigoe T, et al. Among authors: uramoto h. Anticancer Drugs. 2002 Mar;13(3):237-43. doi: 10.1097/00001813-200203000-00005. Anticancer Drugs. 2002. PMID: 11984067 Review.
In this minireview, we describe the structure and function of certain proton pumps overexpressed in many tumors--vacuolar H(+)-ATPases--and consider their potential as targets for cancer chemotherapy....
In this minireview, we describe the structure and function of certain proton pumps overexpressed in many tumors--vacuolar H(+)-ATPase …
Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agents.
Torigoe T, Izumi H, Ishiguchi H, Uramoto H, Murakami T, Ise T, Yoshida Y, Tanabe M, Nomoto M, Itoh H, Kohno K. Torigoe T, et al. Among authors: uramoto h. J Biol Chem. 2002 Sep 27;277(39):36534-43. doi: 10.1074/jbc.M202605200. Epub 2002 Jul 19. J Biol Chem. 2002. PMID: 12133827
We have isolated two overlapping genomic clones that contain the 5'-terminal portion of the human vacuolar H(+)-ATPase c subunit (ATP6L) gene. ...Thus, the two transcription factors, Sp1 and Oct1 interact, in an adaptive response to DNA damage, by up-regulating expression …
We have isolated two overlapping genomic clones that contain the 5'-terminal portion of the human vacuolar H(+)-ATPase c subunit (ATP …
Expression of deltaNp73 predicts poor prognosis in lung cancer.
Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Morita M, Funa K, Yasumoto K. Uramoto H, et al. Clin Cancer Res. 2004 Oct 15;10(20):6905-11. doi: 10.1158/1078-0432.CCR-04-0290. Clin Cancer Res. 2004. PMID: 15501968
Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer.
Oyama T, Morita M, Isse T, Kagawa N, Nakata S, So T, Mizukami M, Ichiki Y, Ono K, Sugaya M, Uramoto H, Yoshimatsu T, Hanagiri T, Sugio K, Kawamoto T, Yasumoto K. Oyama T, et al. Among authors: uramoto h. Front Biosci. 2005 May 1;10:1156-61. doi: 10.2741/1608. Front Biosci. 2005. PMID: 15769614
Molecular genetic tumor markers in non-small cell lung cancer.
Oyama T, Osaki T, Baba T, Nagata Y, Mizukami M, So T, Nakata S, Ichiki Y, Uramoto H, Sugaya M, Yoshimatsu T, Morita M, Hanagiri T, Sugio K, Kawamoto T, Yasumoto K. Oyama T, et al. Among authors: uramoto h. Anticancer Res. 2005 Mar-Apr;25(2B):1193-6. Anticancer Res. 2005. PMID: 15865065 Review.
Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance.
Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Yoshimastu T, Morita M, Yasumoto K. Uramoto H, et al. Lung Cancer. 2005 Jul;49(1):55-62. doi: 10.1016/j.lungcan.2004.12.011. Lung Cancer. 2005. PMID: 15949590
334 results
Jump to page
Feedback